Number of patients evaluated | 157 | |
---|---|---|
Age (median, interquartile range) | 71 (63–79) | |
N | % | |
Sex | ||
Male | 117 | 74.5 |
Female | 40 | 25.5 |
Patient location before admission | ||
Home | 123 | 78.3 |
Other hospital | 18 | 11.5 |
Long-term care facility | 11 | 7.0 |
Other | 5 | 3.2 |
Geographical area (Italy) | ||
North | 111 | 70.7 |
Center | 27 | 17.2 |
South | 19 | 12.1 |
Period of hospitalisation | ||
February 2020-September 2020 | 72 | 45.9 |
October 2020-April 2021 | 85 | 54.1 |
Comorbidities | ||
Chronic respiratory disease | 32 | 20.4 |
Neoplastic disease | 19 | 12.1 |
Diabetes | 42 | 26.8 |
Chronic renal failure | 26 | 16.6 |
Antibiotics in the first 48 h from admission | ||
Any | 95 | 60.5 |
Azithromycin | 40 | 25.5 |
Ceftriaxone | 43 | 27.4 |
Piperacillin-tazobactam | 22 | 14.0 |
Others | 26 | 16.6 |
Steroids in the first 48 h from admission | 72 | 45.9 |
Admission to Intensive Care Unit (ICU) | 111 | 70.7 |
Level of care at first positive blood culture | ||
ICU | 51 | 60.7 |
Other wards | 33 | 39.3 |
Level of care at first positive lower respiratory tract culture | ||
ICU | 95 | 88.8 |
Other wards | 12 | 11.2 |
Level of care at first positive urinary antigen test (for S. pnemoniae or L. pneumophila) | ||
ICU | 3 | 18.8 |
Other wards | 13 | 81.2 |
Sepsis reported as a cause of death in the death certificate | 57 | 36.3 |